Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription.
A Muir, … , J Krischer, N Maclaren
A Muir, … , J Krischer, N Maclaren
Published February 1, 1995
Citation Information: J Clin Invest. 1995;95(2):628-634. https://doi.org/10.1172/JCI117707.
View: Text | PDF
Research Article Article has an altmetric score of 3

Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription.

  • Text
  • PDF
Abstract

We reported previously that daily injections of isophane insulin prevented both hyperglycemia and insulitis in nonobese diabetic (NOD) mice (Atkinson, M., N. Maclaren; and R. Luchetta. 1990. Diabetes. 39:933-937). The possible mechanisms responsible include reduced immunogenicity of pancreatic beta-cells from "beta-cell rest" and induced active immunoregulation to insulin (Aaen, IK., J. Rygaard, K. Josefsen, H. Petersen, C. H. Brogren, T. Horn, and K. Buschard. 1990. Diabetes. 39:697-701). We report here that intermittent immunizations with insulin or its metabolically inactive B-chain in incomplete Freund's adjuvant also prevent diabetes in NOD mice, whereas immunizations with A-chain insulin or with BSA do not. Adoptive transfer of splenocytes from B-chain insulin-immunized mice prevented diabetes in recipients co-infused with diabetogenic spleen cells, an effect that was abolished by prior in vivo elimination of either CD4+ or CD8+ cells. Insulin immunization did not reduce the extent of intraislet inflammation (insulitis); however, it did abolish expression of IFN-gamma mRNA within the insulitis lesions. Immunizations with insulin thus induce an active suppressive response to determinants on the B-chain that converts the insulitis lesion from one that is destructive to one that is protective.

Authors

A Muir, A Peck, M Clare-Salzler, Y H Song, J Cornelius, R Luchetta, J Krischer, N Maclaren

×

Total citations by year

Year: 2022 2021 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1993 1991 Total
Citations: 2 2 1 2 2 2 6 2 6 8 5 4 2 10 2 11 12 8 11 15 11 13 12 17 15 6 1 1 189
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (189)

Title and authors Publication Year
CX3CL1 Worsens Cardiorenal Dysfunction and Serves as a Therapeutic Target of Canagliflozin for Cardiorenal Syndrome
C Zheng, W Xuan, Z Chen, R Zhang, X Huang, Y Zhu, S Ma, K Chen, L Chen, M He, H Lin, W Liao, J Bin, Y Liao
Frontiers in pharmacology 2022
Interferon Family Cytokines in Obesity and Insulin Sensitivity.
Huang LY, Chiu CJ, Hsing CH, Hsu YH
Cells 2022
100 Years of insulin: Lifesaver, immune target, and potential remedy for prevention
A Ziegler, T Danne, C Daniel, E Bonifacio
The American Journal of Medicine 2021
Auto-antigen and Immunomodulatory Agent–Based Approaches for Antigen-Specific Tolerance in NOD Mice
EJ Bassin, JD Piganelli, SR Little
Current Diabetes Reports 2021
Immature Dendritic Cell Therapy Confers Durable Immune Modulation in an Antigen-Dependent and Antigen-Independent Manner in Nonobese Diabetic Mice
J Lo, CQ Xia, R Peng, MJ Clare-Salzler
Journal of Immunology Research 2018
Metabolically inactive insulin analogue does not prevent autoimmune diabetes in NOD mice
J Grönholm, PP Pagni, MN Pham, CB Gibson, PF Macomber, JL Vela, M Herrath, MJ Lenardo
Diabetologia 2017
Metabolically inactive insulin: friend or foe in the prevention of autoimmune diabetes?
M Knip
Diabetologia 2017
Analysis of antigen specific T cells in diabetes – Lessons from pre-clinical studies and early clinical trials
B Krishnamurthy, C Selck, J Chee, G Jhala, TW Kay
Journal of Autoimmunity 2016
Regenerative Medicine - from Protocol to Patient
LC Zelarayán, MP Zafiriou, WH Zimmermann
Regenerative Medicine - from Protocol to Patient 2016
Thinking bedside at the bench: the NOD mouse model of T1DM
JC Reed, KC Herold
Nature Reviews Endocrinology 2015
The Effect of DPT-1 Intravenous Insulin Infusion and Daily Subcutaneous Insulin on Endogenous Insulin Secretion and Postprandial Glucose Tolerance
W Hao, CJ Greenbaum, JP Krischer, D Cuthbertson, JB Marks, JP Palmer
Diabetes care 2015
MAS-1 adjuvant immunotherapy generates robust Th2 type and regulatory immune responses providing long-term protection from diabetes in late-stage pre-diabetic NOD mice
L Zhang, P Londono, L Yu, S Grimes, P Blackburn, P Gottlieb, GS Eisenbarth
Autoimmunity 2014
Monoclonal antibody blocking the recognition of an insulin peptide-MHC complex modulates type 1 diabetes
L Zhang, F Crawford, L Yu, A Michels, M Nakayama, HW Davidson, JW Kappler, GS Eisenbarth
Proceedings of the National Academy of Sciences 2014
ZnT8-Reactive T Cells Are Weakly Pathogenic in NOD Mice but Can Participate in Diabetes Under Inflammatory Conditions
DK Nayak, B Calderon, AN Vomund, ER Unanue
Diabetes 2014
IGRP and insulin vaccination induce CD8+ T cell-mediated autoimmune diabetes in the RIP-CD80GP mouse: Autoimmune diabetes induction in RIP-CD80GP mice
YF Fuchs, K Adler, A Lindner, A Karasinsky, C Wilhelm, M Weigelt, H Balke, K Förtsch, LF Mortler-Hildebrandt, DM Harlan, K Pechhold, AG Ziegler, E Bonifacio
Clinical & Experimental Immunology 2014
Antigen Presentation in the Autoimmune Diabetes of the NOD Mouse
ER Unanue
Annual Review of Immunology 2014
The cytokine production of peripheral blood mononuclear cells reflects the autoantibody profile of patients suffering from type 1 diabetes
J Labikova, J Vcelakova, T Ulmannova, L Petruzelkova, S Kolouskova, K Stechova
Cytokine 2014
Inducing immune tolerance: a focus on Type 1 diabetes mellitus
D Xu, S Prasad, SD Miller
Diabetes Management 2013
B7-H4.Ig inhibits the development of Type 1 diabetes by regulating Th17 cells in NOD mice
IF Lee, X Wang, J Hao, N Akhoundsadegh, L Chen, L Liu, S Langermann, D Ou, GL Warnock
Cellular Immunology 2013
Islet autoantigens: structure, function, localization, and regulation
P Arvan, M Pietropaolo, D Ostrov, CJ Rhodes
Cold Spring Harbor Perspectives in Medicine 2012
Antigen-Specific Therapeutic Approaches in Type 1 Diabetes
X Clemente-Casares, S Tsai, C Huang, P Santamaria
Cold Spring Harbor Perspectives in Medicine 2012
Regenerative Medicine
S Ricco, L Boone, JF Peroni
Equine Surgery 2012
Short-term subcutaneous insulin treatment delays but does not prevent diabetes in NOD mice: Immunomodulation
V Brezar, S Culina, MC Gagnerault, R Mallone
European Journal of Immunology 2012
MECHANISMS IN ENDOCRINOLOGY: Insulin and type 1 diabetes: immune connections
S Culina, V Brezar, R Mallone
European Journal of Endocrinology 2012
Animal Models in Diabetes Research
HG Joost, H Al-Hasani, A Schürmann
2012
Beyond the Hormone: Insulin as an Autoimmune Target in Type 1 Diabetes
V Brezar, JC Carel, C Boitard, R Mallone
Endocrine reviews 2011
Genetic vaccination for re-establishing T-cell tolerance in type 1 diabetes
MC Johnson, B Wang, R Tisch
Human vaccines 2011
Current State of Type 1 Diabetes Immunotherapy: Incremental Advances, Huge Leaps, or More of the Same?
B Phillips, M Trucco, N Giannoukakis
Clinical and Developmental Immunology 2011
GAD autoantibody epitope pattern after GAD-alum treatment in children and adolescents with type 1 diabetes
C Skoglund, M Chéramy, R Casas, J Ludvigsson, CS Hampe
Pediatric Diabetes 2011
Immunization with an insulin peptide-MHC complex to prevent type 1 diabetes of NOD mice
L Zhang, BD Stadinski, A Michels, JW Kappler, GS Eisenbarth
Diabetes/Metabolism Research and Reviews 2011
Inverse vaccination with islet autoantigens to halt progression of autoimmune diabetes
SA Hinke
Drug Development Research 2011
Williams Textbook of Endocrinology
DW Cooke, SA Divall, S Radovick
Williams Textbook of Endocrinology 2011
Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies
TL van Belle, KT Coppieters, MG von Herrath
Physiological reviews 2011
Immune therapy for type 1 diabetes mellitus—what is unique about anti-CD3 antibodies?
L Chatenoud
Nature Reviews Endocrinology 2010
Molecular Targeting of Islet Autoantigens
B Stadinski, J Kappler, GS Eisenbarth
Immunity 2010
Early induction of GAD65-reactive Th2 response in type 1 diabetic children treated with alum-formulated GAD65
S Axelsson, M Hjorth, L Åkerman, J Ludvigsson, R Casas
Diabetes/Metabolism Research and Reviews 2010
Administration of a determinant of preproinsulin can induce regulatory T cells and suppress anti-islet autoimmunity in NOD mice
T Arai, H Moriyama, M Shimizu, H Sasaki, M Kishi, Y Okumachi, H Yasuda, K Hara, K Yokono, M Nagata
Clinical Immunology 2010
Textbook of Diabetes: Holt/Textbook of Diabetes
HE Larsson, AJ Delli, SA Ivarsson, Å Lernmark
Textbook of Diabetes: Holt/Textbook of Diabetes 2010
Immunotherapy for the Prevention and Treatment of Type 1 Diabetes: Optimizing the path from bench to bedside
D Bresson, M Herrath
Diabetes care 2009
Transgenically Induced GAD Tolerance Curtails the Development of Early  -Cell Autoreactivities but Causes the Subsequent Development of Supernormal Autoreactivities to Other  -Cell Antigens
J Tian, H Dang, H Boehmer, E Jaeckel, DL Kaufman
Diabetes 2009
DNA vaccine containing the mycobacterial hsp65 gene prevented insulitis in MLD-STZ diabetes
RR Santos, A Sartori, DS Lima, PR Souza, AA Coelho-Castelo, VL Bonato, CL Silva
Journal of immune based therapies and vaccines 2009
Insulin treatment in IA-2A-positive relatives of type 1 diabetic patients
E Vandemeulebroucke, FK Gorus, K Decochez, I Weets, B Keymeulen, CD Block, J Tits, DG Pipeleers, C Mathieu
Diabetes & Metabolism 2009
Parameters influencing antigen-specific immunotherapy for Type 1 diabetes
B Wang, R Tisch
Immunologic Research 2008
Parameters influencing antigen-specific immunotherapy for Type 1 diabetes
B Wang, R Tisch
Immunologic Research 2008
The Type and Frequency of Immunoregulatory CD4+ T-Cells Govern the Efficacy of Antigen-Specific Immunotherapy in Nonobese Diabetic Mice
SM Pop, CP Wong, Q He, Y Wang, MA Wallet, KS Goudy, R Tisch
Diabetes 2007
Translational Mini-Review Series on Type 1 Diabetes: Immune-based therapeutic approaches for type 1 diabetes
T Staeva-Vieira, M Peakman, M Herrath
Clinical & Experimental Immunology 2007
Selected Mechanistic Studies and Future Directions for Thymoglobulin
M Ruzek, J Dzuris, L Gao, R Bigelow, J Waire, A Scaria, S Nahill, J Williams
Transplantation 2007
Suppression of diabetes in non-obese diabetic (NOD) mice by oral administration of a cholera toxin B subunit–insulin B chain fusion protein vaccine produced in silkworm
Z Gong, Y Jin, Y Zhang
Vaccine 2007
Dominant CTL-inducing epitopes on GAD65 are adjacent to or overlap with dominant Th-inducing epitopes
RY Busick, C Aguilera, A Quinn
Clinical Immunology 2007
Insulin as a T cell antigen in type 1 diabetes supported by the evidence from the insulin knockout NOD mice
H Moriyama, M Nagata, T Arai, Y Okumachi, K Yamada, R Kotani, H Yasuda, K Hara, K Yokono
Diabetes Research and Clinical Practice 2007
Type 1 Diabetes in Adults: Principles and Practice
J Cropsey, M Fineman
Type 1 Diabetes in Adults: Principles and Practice 2007
Étiologie et physiopathologie du diabète de type 1
D Dubois-Laforgue
EMC - Endocrinologie - Nutrition 2007
Immunological Responses to Exogenous Insulin
SE Fineberg, TT Kawabata, D Finco-Kent, RJ Fountaine, GL Finch, AS Krasner
Endocrine reviews 2007
Immune Regulation and Immunotherapy in Autoimmune Disease
J Zhang
2007
Tissue inhibitor of metalloproteinase-2 inhibits T-cell infiltration and preserves pancreatic β-cell function in an in vitro type 1 diabetes mellitus model
CC Woods, K Sundar, C Tessler, TW Lebsack, L Grainger, A Nielsen, D Bleich, D DeLuca
Journal of Autoimmunity 2006
The Autoimmune Diseases
I Kang, J Craft
The Autoimmune Diseases 2006
Single cell analysis shows decreasing FoxP3 and TGFbeta1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetes
SM Pop, CP Wong, DA Culton, SH Clarke, R Tisch
Journal of Experimental Medicine 2005
Nutrition and Disease Prevention
K Imaizumi
Soy in Health and Disease Prevention 2005
A Comprehensive Review of Interventions in the NOD Mouse and Implications for Translation
LK Shoda, DL Young, S Ramanujan, CC Whiting, MA Atkinson, JA Bluestone, GS Eisenbarth, D Mathis, AA Rossini, SE Campbell, R Kahn, HT Kreuwel
Immunity 2005
Interferon-γ-induced regulation of the pancreatic derived cytokine FAM3B in islets and insulin-secreting βTC3 cells
W Xu, Z Gao, J Wu, BA Wolf
Molecular and Cellular Endocrinology 2005
Immune modulation for prevention of type 1 diabetes mellitus
I Raz, R Eldor, Y Naparstek
Trends in Biotechnology 2005
Antigen-Specific Induction of Regulatory T Cells for Type 1 Diabetes Therapy
C Filippi, D Bresson, M Herrath
International Reviews of Immunology 2005
Innovative Immune-Based Therapeutic Approaches for the Treatment of Type 1 Diabetes Mellitus
R Eldor, IR Cohen, I Raz
International Reviews of Immunology 2005
T cell targeted immunotherapy for autoimmune disease
E Lee, AA Sinha
Autoimmunity 2005
Single cell analysis shows decreasing FoxP3 and TGFβ1 coexpressing CD4 + CD25 + regulatory T cells during autoimmune diabetes
SM Pop, CP Wong, DA Culton, SH Clarke, R Tisch
Journal of Experimental Medicine 2005
Regulatory T Cells in Inflammation
LS Taams, MH Wauben, AN Akbar
2005
Antigen-Based Therapies Using Ignored Determinants of β Cell Antigens Can More Effectively Inhibit Late-Stage Autoimmune Disease in Diabetes-Prone Mice
AP Olcott, J Tian, V Walker, H Dang, B Middleton, L Adorini, L Washburn, DL Kaufman
Journal of immunology (Baltimore, Md. : 1950) 2005
Expression of preproinsulin-2 gene shapes the immune response to preproinsulin in normal mice
B Faideau, JP Briand, C Lotton, I Tardivel, P Halbout, J Jami, JF Elliott, P Krief, S Muller, C Boitard, JC Carel
Journal of immunology (Baltimore, Md. : 1950) 2004
T cells recognize multiple GAD65 and proinsulin epitopes in human type 1 diabetes, suggesting determinant spreading
PA Ott, MT Dittrich, BA Herzog, R Guerkov, PA Gottlieb, AL Putnam, I Durinovic-Bello, BO Boehm, M Tary-Lehmann, PV Lehmann
Journal of Clinical Immunology 2004
DNA vaccination encoding glutamic acid decarboxylase can enhance insulitis and diabetes in correlation with a specific Th2/3 CD4 T cell response in non-obese diabetic mice
A Gauvrit, M Debailleul, AT Vu, P Sai, JM Bach
Clinical & Experimental Immunology 2004
Regulatory T cells and type 1 diabetes
D Homann, M Herrath
Clinical Immunology 2004
Regulatory T-cells in type 1 diabetes
AE Juedes, MG von Herrath
Diabetes/Metabolism Research and Reviews 2004
Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes
E Jaeckel, MA Lipes, H Boehmer
Nature Immunology 2004
Molecular Pathways Altered by Insulin B9-23 Immunization
SE Eckenrode, QG Ruan, CD Collins, P Yang, RA Mcindoe, A Muir, JX She
Annals of the New York Academy of Sciences 2004
Oral Insulin Therapy to Prevent Progression of Immune-Mediated (Type 1) Diabetes
B Ergun-Longmire, J Marker, A Zeidler, R Rapaport, P Raskin, B Bode, D Schatz, A Vargas, D Rogers, S Schwartz, J Malone, J Krischer, NK Maclaren
Annals of the New York Academy of Sciences 2004
Specific antigen vaccination to treat autoimmune disease
H McDevitt
Proceedings of the National Academy of Sciences 2004
Characteristics of testicular lesions in mice infected with a low dose of encephalomyocarditis (EMC) virus
A Yamanouchiueno, Y Nakayama, K Doi
Experimental and Molecular Pathology 2004
Autoimmune diabetes: More than just one flavor?
HK Chiu, JP Palmer
Journal of Endocrinological Investigation 2004
Effects of Tacrolimus (FK506) on Encephalomyocarditic Virus-Induced Diabetes in Mice
S Yama, W Nishioka, Y Hirokami, R Setoguchi, N Takeyama, K Saeki, Y Matsumoto, T Hayashi, K Doi, T Onodera
Microbiology and Immunology 2004
Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient non obese diabetic mice
Karine Thébault-Baumont, Danielle Dubois-Laforgue, Patricia Krief, Jean-Paul Briand, Philippe Halbout, Karine Vallon-Geoffroy, Joëlle Morin, Véronique Laloux, Agnès Lehuen, Jean-Claude Carel, Jacques Jami, Sylviane Muller, Christian Boitard
Journal of Clinical Investigation 2003
Latent autoimmune diabetes in adults (LADA)
Ramachandra G Naik, Jerry P Palmer
Reviews in Endocrine and Metabolic Disorders 2003
Th1 and Th2 Pancreatic Inflammation Differentially Affects Homing of Islet-Reactive CD4 Cells in Nonobese Diabetic Mice
NJ Hill, KV Gunst, N Sarvetnick
Journal of immunology (Baltimore, Md. : 1950) 2003
More Stringent Conditions of Plasmid DNA Vaccination Are Required to Protect Grafted Versus Endogenous Islets in Nonobese Diabetic Mice
C Seifarth, S Pop, B Liu, CP Wong, R Tisch
Journal of immunology (Baltimore, Md. : 1950) 2003
Characterization of antibody responses to endogenous and exogenous antigen in the nonobese diabetic mouse
K Koczwara, M Schenker, S Schmid, K Kredel, AG Ziegler, E Bonifacio
Clinical Immunology 2003
Absence of the T-bet Gene Coding for the Th1-Related Transcription Factor Does Not Affect Diabetes-Associated Phenotypes in Balb/c Mice
E Melanitou, E Liu, D Miao, L Yu, LH Glimcher, G Eisenbarth
Annals of the New York Academy of Sciences 2003
Cytokines and Chemokines in Autoimmune Disease
P Santamaria
2003
Systemic Administration of IL-18 Promotes Diabetes Development in Young Nonobese Diabetic Mice
Y Oikawa, A Shimada, A Kasuga, J Morimoto, T Osaki, H Tahara, T Miyazaki, F Tashiro, E Yamato, J Miyazaki, T Saruta
Journal of immunology (Baltimore, Md. : 1950) 2003
Insulin-Specific Tolerance in Diabetes
PA Gottlieb, GS Eisenbarth
Clinical Immunology 2002
Immunomodulatory vaccination in autoimmune disease
I Urbanek-Ruiz, PJ Ruiz, L Steinman, CG Fathman
Endocrinology & Metabolism Clinics of North America 2002
Environmental factors in the etiology of type 1 diabetes
HK �kerblom, O Vaarala, H Hy�ty, J Ilonen, M Knip
American Journal of Medical Genetics 2002
Immunotherapy of insulin-dependent diabetes mellitus
EL Masteller, JA Bluestone
Current Opinion in Immunology 2002
CD4(+) T cells from glutamic acid decarboxylase (GAD)65-specific T cell receptor transgenic mice are not diabetogenic and can delay diabetes transfer
KV Tarbell, M Lee, E Ranheim, CC Chao, M Sanna, SK Kim, P Dickie, L Teyton, M Davis, H McDevitt
Journal of Experimental Medicine 2002
Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic-polycytidylic acid) and an insulin self-peptide
H Moriyama, L Wen, N Abiru, E Liu, L Yu, D Miao, R Gianani, FS Wong, GS Eisenbarth
Proceedings of the National Academy of Sciences 2002
Immunotherapy of type 1 diabetes: lessons for other autoimmune diseases
JF Bach
Arthritis research 2002
Antigen-based immunotherapy drives the precocious development of autoimmunity
J Tian, AP Olcott, DL Kaufman
Journal of immunology (Baltimore, Md. : 1950) 2002
Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptide
David G Alleva, Amitabh Gaur, Liping Jin, Dale Wegmann, Peter A Gottlieb, Anil Pahuja, Eric B Johnson, Theresa Motheral, Amy Putnam, Paul D Crowe, Nicholas Ling, Stefen A Boehme, Paul J Conlon
Diabetes 2002
NKT cell defects in NOD mice suggest therapeutic opportunities
Anjli Kukreja, Guilia Costi, John Marker, Chen Hui Zhang, Sunil Sinha, Zhong Sun, Noel Maclaren
Journal of Autoimmunity 2002
T Cell Response to Preproinsulin I and II in the Nonobese Diabetic Mouse
P Halbout, JP Briand, C Bécourt, S Muller, C Boitard
Journal of immunology (Baltimore, Md. : 1950) 2002
A disease-associated cellular immune response in type I diabetics to an immunodominant epitope of insulin
David G. Alleva, Paul D. Crowe, Liping Jin, William W. Kwok, Nicholas Ling, Michael Gottschalk, Paul J. Conlon, Peter A. Gottlieb, Amy L. Putnam, Amitabh Gaur
Journal of Clinical Investigation 2001
Evidence that a peptide spanning the B-C junction of proinsulin is an early Autoantigen epitope in the pathogenesis of type 1 diabetes
W Chen, I Bergerot, JF Elliott, LC Harrison, N Abiru, GS Eisenbarth, TL Delovitch
Journal of immunology (Baltimore, Md. : 1950) 2001
Plasmid DNAs Encoding Insulin and Glutamic Acid Decarboxylase 65 Have Distinct Effects on the Progression of Autoimmune Diabetes in Nonobese Diabetic Mice
DJ Weaver, B Liu, R Tisch
Journal of immunology (Baltimore, Md. : 1950) 2001
TOLERANCE TOISLETAUTOANTIGENS INTYPE1 DIABETES
JF Bach, L Chatenoud
Annual Review of Immunology 2001
Prospects for predicting and stopping the development of type 1 of diabetes
FK Gorus, DG Pipeleers, BD Registry
Best Practice & Research Clinical Endocrinology & Metabolism 2001
Immunization with DNA Encoding an Immunodominant Peptide of Insulin Prevents Diabetes in NOD Mice
I Urbanek-Ruiz, PJ Ruiz, V Paragas, H Garren, L Steinman, CG Fathman
Clinical Immunology 2001
New therapeutic approaches to type 1 diabetes: from prevention to cellular or gene therapies
C Thivolet
Clinical Endocrinology 2001
Diabetes Vaccines: A Future to be Realized
K Lin-Su, A Kukreja, NK MacLaren
Diabetes Technology & Therapeutics 2001
Pathophysiology of Immune-Mediated (Type 1) Diabetes Mellitus
M Abel, M Krokowski
BioDrugs 2001
Peptide and major histocompatibility complex-specific breaking of humoral tolerance to native insulin with the B9-23 peptide in diabetes-prone and normal mice
N Abiru, AK Maniatis, L Yu, D Miao, H Moriyama, D Wegmann, GS Eisenbarth
Diabetes 2001
Pancreatic stem cells: building blocks for a better surrogate islet to treat type 1 diabetes
AB Peck, M Chaudhari, JG Cornelius, VK Ramiya
Annals of Medicine 2001
Tacrolimus, but not Cyclosporine A, significantly increases expression of ICAM-1 and IFN-? in the NOD mouse
G Papaccio, MV Latronico, A Graziano, A Lanza, M Pedull
Journal of Cellular Biochemistry 2001
Antigen-Specific Mediated Suppression of β Cell Autoimmunity by Plasmid DNA Vaccination
R Tisch, B Wang, DJ Weaver, B Liu, T Bui, J Arthos, DV Serreze
Journal of immunology (Baltimore, Md. : 1950) 2001
A Glutamic Acid Decarboxylase 65-Specific Th2 Cell Clone Immunoregulates Autoimmune Diabetes in Nonobese Diabetic Mice
R Tisch, B Wang, MA Atkinson, DV Serreze, R Friedline
Journal of immunology (Baltimore, Md. : 1950) 2001
Therapeutic Alteration of Insulin-Dependent Diabetes Mellitus Progression by T Cell Tolerance to Glutamic Acid Decarboxylase 65 Peptides In Vitro and In Vivo
SS Wilson, TC White, D DeLuca
Journal of immunology (Baltimore, Md. : 1950) 2001
Does GAD Have a Unique Role in Triggering IDDM?
S Baekkeskov, J Kanaani, JC Jaume, S Kash
Journal of Autoimmunity 2000
Analysis of Cytokine mRNA Expression in Pancreatic Islets of Nonobese Diabetic Mice
H Hirai, Y Kaino, T Ito, K Kida
Journal of Pediatric Endocrinology and Metabolism 2000
Endogenous Ecotropic Murine Leukemia Viral (MuLV) Envelope Protein as a New Autoantigen Reactive with Non-obese Diabetic Mice Sera
SE Choi, KS Kim, KH Kim, UY Choi, HM Kim, JW Yoon, Y Kang
Journal of Autoimmunity 2000
Prevention of Autoimmune Diabetes by Oral Administration of Syngeneic Pancreatic Extract to Young NOD Mice
S Reddy, N Stefanovic, M Karanam
Pancreas 2000
Dual Overlapping Peptides Recognized by Insulin Peptide B:9–23 T Cell Receptor AV13S3 T Cell Clones of the NOD Mouse
N Abiru, D Wegmann, E Kawasaki, P Gottlieb, E Simone, GS Eisenbarth
Journal of Autoimmunity 2000
The route of administration of an immunodominant peptide derived from heat-shock protein 65 dramatically affects disease outcome in pristane-induced arthritis
JN Francis, AG Lamont, SJ Thompson
Immunology 2000
Indirubin inhibits inflammatory reactions in delayed-type hypersensitivity
T Kunikata, T Tatefuji, H Aga, K Iwaki, M Ikeda, M Kurimoto
European Journal of Pharmacology 2000
Prevention of Type 1 Diabetes: Is Now the Time?1
DJ Becker, RE LaPorte, I Libman, M Pietropaolo, HM Dosch
The Journal of clinical endocrinology and metabolism 2000
Multiple Genes/Multiple Autoantigens Role in Type 1 Diabetes
N Abiru, GS Eisenbarth
Clinical Reviews in Allergy & Immunology 2000
Immunotherapy of Immune-Mediated Diabetes: Present and Future
N Maclaren
Clinical Reviews in Allergy & Immunology 2000
New Concepts of the Etiopathogenesis and Treatment of Insulin-Dependent Diabetes Mellitus
JF Bach
Clinical Reviews in Allergy & Immunology 2000
NKT Cell Cytokine Imbalance in Murine Diabetes Mellitus
AB Frey, TD Rao
Autoimmunity 1999
Detection of dendritic cells in the non-obese diabetic (NOD) mouse islet pancreas infiltrate is correlated with Th2-cytokine production
G Papaccio, AD Luca, BD Luca, FA Pisanti, S Zarrilli
Journal of Cellular Biochemistry 1999
Immunogenetics of insulin-dependent diabetes mellitus
K Kida, Y Kaino, T Ito, H Hirai, K Nakamura
Acta Paediatrica 1999
Autoreactive CD4+ T Cells Protect from Autoimmune Diabetes via Bystander Suppression Using the IL-4/Stat6 Pathway
D Homann, A Holz, A Bot, B Coon, T Wolfe, J Petersen, TP Dyrberg, MJ Grusby, MG von Herrath
Immunity 1999
An Alternative Perspective to the Immune Response in Autoimmune Exocrinopathy: Induction of Functional Quiescence Rather Than Destructive Autoaggression
MG Humphreys-Beher, J Brayer, S Yamachika, AB Peck, R Jonsson
Scandinavian Journal of Immunology 1999
Human insulin B chain but not A chain decreases the rate of diabetes in BB rats
HY Song, MM Abad, CP Mahoney, RC McEvoy
Diabetes Research and Clinical Practice 1999
New concepts for the development of autoimmune exocrinopathy derived from studies with the NOD mouse model
MG Humphreys-Beher, AB Peck
Archives of Oral Biology 1999
The use of islet autoantibody markers in the prediction of autoimmune type 1 diabetes
WE Winter
Clinical Immunology Newsletter 1999
Antigen-based immunotherapy for autoimmune disease: from animal models to humans?
J Tian, A Olcott, L Hanssen, D Zekzer, DL Kaufman
Immunology Today 1999
The Decade of Autoimmunity
BD Stollar
The Decade of Autoimmunity 1999
Molecular and Cellular Pediatric Endocrinology
S Handwerger
1999
Autoimmune Endocrinopathies
R Volpé
1999
T-cell response to proinsulin and insulin in type 1 and pretype 1 diabetes
D Dubois-LaForgue, J C Carel, P F Bougnères, J G Guillet, C Boitard
Journal of Clinical Immunology 1999
Local expression of immunoregulatory IL-12p40 gene prolonged syngeneic islet graft survival in diabetic NOD mice
H Yasuda, M Nagata, K Arisawa, R Yoshida, K Fujihira, N Okamoto, H Moriyama, M Miki, I Saito, H Hamada, K Yokono, M Kasuga
Journal of Clinical Investigation 1998
Are there unique autoantigens triggering autoimmune diseases?
JF Bach, S Koutouzov, PM Endert
Immunological Reviews 1998
Th1 unresponsiveness can be infectious for unrelated antigens
B Charlton, CG Fathman, RM Slattery
Immunology and Cell Biology 1998
Prevention of Diabetes in Non-Obese Diabetic (NOD) Mice by Short-Term and High-Dose IGF-I Treatment
Y Kaino, H Hirai, T Ito, K Kida
Journal of Pediatric Endocrinology and Metabolism 1998
Antigen-based T-cell-targeted immunotherapy: recent developments in autoimmunity and allergy
C Stemmer, G Guichard
Expert Opinion on Therapeutic Patents 1998
Recombinant Adenovirus Encoding gp100 Modulates Experimental Melanin-Protein Induced Uveitis (EMIU)
CC Chan, Y Li, B Sun, Q Li, DM Matteson, DF Shen, RB Nussenblatt, Y Zhai
Journal of Autoimmunity 1998
Protection from Insulin Dependent Diabetes Mellitus Afforded by Insulin Antigens in Incomplete Freund's Adjuvant Depends on Route of Administration
P Hutchings, A Cooke
Journal of Autoimmunity 1998
PREVENTION OF TYPE 1 DIABETES
A Rabinovitch, JS Skyler
Medical Clinics of North America 1998
Cytokines and Their Roles in Pancreatic Islet β-Cell Destruction and Insulin-Dependent Diabetes Mellitus
A Rabinovitch, WL Suarez-Pinzon
Biochemical Pharmacology 1998
Administration of IL-4 Prevents Autoimmune Diabetes but Enhances Pancreatic Insulitis in NOD Mice
Y Tominaga, M Nagata, H Yasuda, N Okamoto, K Arisawa, H Moriyama, M Miki, K Yokono, M Kasuga
Clinical Immunology and Immunopathology 1998
Interferon-α and interferon-γ differentially affect pancreatic β-cell phenotype and function
ME Baldeón, T Chun, HR Gaskins
American journal of physiology. Cell physiology 1998
Endocrine Autoimmunity and Associated Conditions
AP Weetman
1998
Metabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice
DG Karounos, JS Bryson, DA Cohen
Journal of Clinical Investigation 1997
Oral Administration of the Immunodominant B-chain of Insulin Reduces Diabetes in a Co-transfer Model of Diabetes in the NOD Mouse and is Associated with a Switch from Th1 to Th2 Cytokines
M Polanski, NS Melican, J Zhang, HL Weiner
Journal of Autoimmunity 1997
Effect of Oral and Intravenous Insulin and Glutamic Acid Decarboxylase in NOD Mice
VK Ramiya, XZ Shang, CH Wasserfall, NK Maclaren
Autoimmunity 1997
The Nonobese Diabetic Mouse as a Model of Autoimmune Diabetes: Immune Dysregulation Gets the NOD
TL Delovitch, B Singh
Immunity 1997
Immunization Therapies in the Prevention of Diabetes
VK Ramiya, MS Lan, CH Wasserfall, AL Notkins, NK Maclaren
Journal of Autoimmunity 1997
Insulin Therapy of Prediabetes Suppresses TH1 Associated Gene Expression in BB Rat Pancreas
H Kolba, U Wörz-Pagenstert, R Kleemann, H Rothe, P Rowsell, S Rastegar, FW Scott
Autoimmunity 1997
T cell receptor restriction of diabetogenic autoimmune NOD T cells
E Simone, D Daniel, N Schloot, P Gottlieb, S Babu, E Kawasaki, D Wegmann, GS Eisenbarth
Proceedings of the National Academy of Sciences 1997
Insulin-dependent diabetes mellitus: the hypothesis of molecular mimicry between islet cell antigens and microorganisms
NK Maclaren, MA Atkinson
Molecular Medicine Today 1997
T Cell Recognition of Human Pre-Proinsulin Peptides Depends on the Polymorphism at HLA DQ Locus: A Study Using HLA DQ8 and DQ6 Transgenic Mice
R Raju, SR Munn, CS David
Human Immunology 1997
Systemic antigen in the treatment of T-cell-mediated autoimmune diseases
R Liblau, R Tisch, N Bercovici, HO McDevitt
Immunology Today 1997
Role of T-cell anergy and suppression in susceptibility to IDDM
I Bergerot, G Arreaza, M Cameron, H Chou, TL Delovitch
Research in Immunology 1997
Tolerance and Uveitis
JF Bach
American Journal of Ophthalmology 1997
Autoimmune Diabetes
DV House, WE Winter
Clinics in Laboratory Medicine 1997
COMBINATION THERAPY WITH CYCLOSPORINE AND INTERLEUKIN-4 OR INTERLEUKIN-10 PROLONGS SURVIVAL OF SYNGENEIC PANCREATIC ISLET GRAFTS IN NONOBESE DIABETIC MICE: Islet Graft Survival Does Not Correlate with mRNA Levels of Type 1 or Type 2 Cytokines, or Transforming Growth Factor-?? in the Islet Grafts1
A Rabinovitch, WL Suarez-Pinzon, O Sorensen, RV Rajotte, RF Power
Transplantation 1997
Clinical Pathology of Pancreatic Disorders
JA Lott
1997
Prevention of Type I Diabetes and Recurrent β-Cell Destruction of Transplanted Islets*
RH Slover, GS Eisenbarth
Endocrine reviews 1997
Pharmacological Approaches to the Prevention of Autoimmune Diabetes:
WE Winter, DV House, D Schatz
Drugs 1997
Le diabète sucré insulino-dépendant: une maladie auto-immune à laquelle participent des cellules T
R Tisch
Annales de l'Institut Pasteur/Actualités 1996
Prevention of Insulin-dependent Diabetes: Where Are We Now?
P Pozzilli
Diabetes/Metabolism Reviews 1996
The Physiological Role of Regulatory T Cells in the Prevention of Autoimmunity: the Function of the Thymus in the Generation of the Regulatory T Cell Subset
A Saoudi, B Seddon, V Heath, D Fowell, D Mason
Immunological Reviews 1996
Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes–prone mice
J Tian, M Clere-Salzler, A Herschenfeld, B Middleton, D Newman, R Mueller, S Arita, C Evans, MA Atkinson, Y Mullen, N Sarvetnick, AJ Tobin, PV Lehmann, DL Kaufman
Nature Medicine 1996
Regulation of autoimmune diabetes: Characteristics of non-islet-antigen specific therapies
LS Gazda, AG Baxter, KJ Lafferty
Immunology and Cell Biology 1996
Insulin-like growth factor I (IGF-I) delays the onset of diabetes in non-obese diabetic (NOD) mice
Y Kaino
Diabetes Research and Clinical Practice 1996
Intranasal Administration of Insulin Peptide B: 9-23 Protects NOD Mice from Diabetes
D Daniel, DR Wegmann
Annals of the New York Academy of Sciences 1996
Immunotherapies in diabetes
VK Ramiya, NK Maclaren
Trends in Endocrinology & Metabolism 1996
New Strategies in Oral Immunotherapy for Diabetes Prevention
A Muir, V Ramiya
Diabetes/Metabolism Reviews 1996
Viruses, cytokines, antigens, and autoimmunity
R Gianani, N Sarvetnick
Proceedings of the National Academy of Sciences 1996
Strategies for preventing type I diabetes mellitus
CF Verge, GS Eisenbarth
The Western journal of medicine 1996
Checkpoints in the progression of autoimmune disease: lessons from diabetes models
I André, A Gonzalez, B Wang, J Katz, C Benoist, D Mathis
Proceedings of the National Academy of Sciences 1996
The thymus contains a high frequency of cells that prevent autoimmune diabetes on transfer into prediabetic recipients
A Saoudi, B Seddon, D Fowell, D Mason
Journal of Experimental Medicine 1996
The nature of autoantigens targeted in autoimmune endocrine diseases
YH Song, Y Li, NK Maclaren
Immunology Today 1996
Lessons from Animal Diabetes VI
E Shafrir
1996
Insulin-dependent diabetes mellitus as a ?-cell targeted disease of immunoregulation
JF Bach
Journal of Autoimmunity 1995
Glutamic acid decarboxylase and other autoantigens in IDDM
GT Nepom
Current Opinion in Immunology 1995
The Th1/Th2 balance in autoimmunity
B Charlton, KJ Lafferty
Current Opinion in Immunology 1995
Isohormonal therapy of endocrine autoimmunity
N Schloot, GS Eisenbarth
Immunology Today 1995
Genetic analysis of type 1 diabetes using whole genome approaches
JA Todd
Proceedings of the National Academy of Sciences 1995
Antigen-specific therapy for autoimmune disease: prospects for the prevention of insulin-dependent diabetes
LC Harrison
Molecular Medicine 1995
Nutrition and Immunology
DM Klurfeld
1993
Insulin-dependent diabetes mellitus
JF Bach
Current Opinion in Immunology 1991

← Previous 1 2 3 … 7 8 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 5 patents
35 readers on Mendeley
See more details